Used in pharmaceutical research as a potential antipsychotic agent due to its affinity for serotonin and dopamine receptors. Shows activity as a 5-HT1A partial agonist and D2 receptor antagonist, making it a candidate for treating psychiatric disorders such as schizophrenia and anxiety. Also investigated for its neuroprotective properties and ability to modulate cognitive function. Its structure allows for blood-brain barrier penetration, enhancing central nervous system effects. Studied in preclinical models for behavioral and neurochemical outcomes.